Robert DiDomenico
Center Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research (CPR), College of Pharmacy
Associate Professor with tenure, College of Pharmacy - Pharmacy Practice
Associate Head, Faculty Affairs & Strategic Initiatives, Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About Heading link
Overview:
Dr. DiDomenico, Pharm.D., FCCP, HFSA, FACC is an Associate Professor in the Department of Pharmacy Practice, a member of the Center for Pharmacoepidemiology and Pharmacoeconomic Research at the University of Illinois at Chicago (UIC), and Cardiovascular Clinical Pharmacist at the University of Illinois Hospital & Health Sciences System with a practice site in inpatient cardiology. He has also served as Residency Program Director for the UIC PGY2 Cardiology Pharmacy residency, mentoring 10 residents in this program between 2008 – 2020. Dr. DiDomenico received his PharmD (1996) and completed three years of post-doctoral training (Pharmacy Practice Residency, 1997; Cardiovascular Pharmacotherapy Fellowship, 1999) at UIC.
He has authored more than 100 peer-reviewed articles, book chapters, and abstracts on topics related to cardiovascular pharmacotherapy and has gained national recognition as a key opinion leader in the areas of heart failure, anticoagulation, and coronary artery disease. He is also an active member of several organizations including the Board of Pharmacy Specialties (BPS), having served as a member of the inaugural Specialty Council on Cardiology. His organizational engagement has earned him fellowship designation in the American College of Clinical Pharmacy (FCCP), American College of Cardiology (FACC), and the Heart Failure Society of America (FHFSA).
Research Interests:
Dr. DiDomenico joined the tenure track in October, 2017. His research focus is optimizing the use of guideline-directed medical therapies (GDMT) in patients patients with cardiovascular disease, particularly those with heart failure and acute coronary syndrome. He is currently working with a group of investigators across the country investigating optimal parenteral anticoagulation strategies in cardiogenic shock patients treated with the Impella percutaneous left ventricular assist device (pVAD). The Impella pVAD is being used increasingly in patients with cardiogenic shock but there is little guidance for nor consistency in anticoagulation practices during Impella pVAD support. Dr. DiDomenico is also investigating approaches aimed at intensifying GDMT in patients hospitalized for acute heart failure in an effort to improve outcomes, including reducing unplanned rehospitalization. His previous work has demonstrated that many patients with HFrEF whose evidence-based therapies are not at goal doses at the time of hospitalization do not have these therapies intensified prior to discharge, potentially contributing to unplanned readmission.
Dr. DiDomenico is also interested in the scholarship of teaching and learning (SoTL), with interests in item-writing, assessment, and delivery.
Teaching Statement:
Dr. DiDomenico has taught in more than 20 core and elective didactic courses. Additionally, he has precepted more than 130 PharmD students completing introductory and advanced pharmacy practice experiences and more than 160 pharmacy residents (more than 240 learning experiences). He has been awarded Preceptor of the Year by students (2006) and residents (2005, 2008), Teacher of the Year Honorable Mention (2005 by Class of 2007), and nominated for the Golden Apple Award (2008).
He also served as Chair of the Educational Policy Committee from 2008 – 2018 during which time the College of Pharmacy implemented distance-learning technology, expanded to a satellite campus in Rockford, IL, revised and implemented a new curriculum, and was re-accredited.
He has given more than 120 invited talks, many for continuing education credit, at various local, regional, national, and international venues.
Teaching and Supervision Heading link
Clinical Research Design (PMPR 487), 1/8/2024 – 4/26/2024
Undergrad Resrch Pharm Pract (PMPR 380), 1/8/2024 – 4/26/2024
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
Clinical Research Design (PMPR 487), 1/9/2023 – 4/28/2023
Block 4: Circulation and Respiration (MDC 604), 3/9/2022 – Present
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 4/29/2022
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 4/29/2022
Spec Project in Pharm Pract (PMPR 390), 1/10/2022 – 4/29/2022
Selected Grants
ICER review: acoramidis (BridgeBio Pharma) for the treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM), Institute for Clinical and Economic Review., 1/1/2024 - 12/31/2024, Obligated Amount: $90001; No Anticipated Amount Set
ASPIRE Advancing Open Educational Resources and Visual Pedagogy for Diverse Stusents, University of Illinois at Urbana-Champaign., 4/1/2023 - 3/31/2024, Obligated Amount: $15000; No Anticipated Amount Set
PRogram to Educate & VaccinatE uNderserved members of The public (PREVENT) Pilot, Mobile Care Fdn., 11/1/2022 - 5/31/2024, Obligated Amount: $17325; Anticipated Amount: $17325
Chicago Metro Vaccine Corps Program, National Center for Advancing Translational Sciences., 6/1/2021 - 5/31/2026, Obligated Amount: $1; No Anticipated Amount Set
COVID-19 Vaccination Chicago Rapid Response Team, Chicago Department of Public Health., 2/1/2021 - 8/1/2021, No Obligated Amount Set; No Anticipated Amount Set
PRogram to Educate & VaccinatE uNderserved members of The public (PREVENT), Mobile Care Fdn., 12/16/2020 - 6/15/2022, Obligated Amount: $58337; Anticipated Amount: $58337
CRRT Service Contract, Chicago Department of Public Health., 7/1/2020 - 3/31/2022, Obligated Amount: $1000000; No Anticipated Amount Set
Stratification of Burnout in Health-system Pharmacists: a Focus on the Ambulatory Care, American College of Clinical Pharmacy Ambulatory Care PRN., 2019 - 2019, Obligated Amount: $750; No Anticipated Amount Set
Contemporary Practice Trends to Reversal of Oral Anticoagulants: A US Based National Survey, CSL Behring., 10/1/2018 - 2/28/2024, Obligated Amount: $52600; Anticipated Amount: $52600
Selected Publications
GOYAL, PARAG, DIDOMENICO, ROBERT J, PRESSLER, SUSAN J, IBEH, CHINWE, WHITE-WILLIAMS, CONNIE, ALLEN, LARRY A, GORODESKI, EIRAN Z, Members, HFSA Scientific Statement Committee, Albert, Nancy, Fudim, Marat, Lekavich, Carolyn, Watson, Kristin, Gulati, Sanjeev, Kalogeropoulos, Andreas, Lewsey, Sabra. (2024). Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement. Journal of Cardiac Failure, 30, (3), 488-504. doi:10.1016/j.cardfail.2024.01.003.
Lau, Anson TC, DiDomenico, Robert J, Kim, Kibum. (2024). Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States. International Journal of Cardiology, 398, 131598. doi:10.1016/j.ijcard.2023.131598.
Bursua, Adam, DiDomenico, Robert, Vuckovic, Karen. (2024). Essentials of Pharmacology. CARLI.
DiDomenico, Robert J, Vardeny, Orly. (2023). Optimizing Heart Failure Therapy Requires All-Hands-on-Deck and a DASH of Technology. Circulation Heart Failure, 16, (9), e010886. doi:10.1161/circheartfailure.123.010886.
Cook, Aaron M, DiDomenico, Robert J. (2023). Easing preceptor stress due to early residency application deadlines. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 6, (4), 327-328. doi:10.1002/jac5.1735.
DiDomenico, Robert, Dobesh, Paul, Finks, Shannon. (2023). Acute coronary syndromes. DiPiro’s Pharmacotherapy: a Pathophysiologic Approach, 12th Edition. McGraw-Hill Education / Medical.
Dobesh, Paul, DiDomenico, Robert, Rogers, Kelly. (2023). Stable Ischemic Heart Disease. DiPiro’s Pharmacotherapy: a Pathophysiologic Approach, 12th Edition. McGraw-Hill Education / Medical.
Sheehan, Amy Heck, DiDomenico, Robert J. (2023). Postgraduate pharmacy training: Much progress and much more to do. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 6, (2), 88-89. doi:10.1002/jac5.1751.
McFarland, M Shawn, Stover, Kayla R, Bhat, Shubha, Coon, Scott, Cooper, Mandelin, DiDomenico, Robert, Herbert, Sophia, Kessler, Sarah, Lee, Michelle, Maddox, Mary Margaret, Quidley, April Miller, Rhoney, Denise, Wooten, Leslie, Zhou, Yi. (2023). Charting a new path forward for pharmacy residency expansion. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 6, (2), 205-212. doi:10.1002/jac5.1748.
Professional Leadership
Communications and Social Media Committee, 11/1/2023 - Present
Educating Patients & Caregivers on HCM Advisory Panel, 9/1/2022 - Present
PhaseBio Pharmaceuticals Pharmacy Advisory Board, 3/18/2022 - 3/18/2022
Task Force on Residency Training, American College of Clinical Pharmacy, 11/1/2021 - 12/31/2022
Annual Scientific Meeting Moderated Poster Session, Heart Failure Society of America, 9/11/2021 - 9/11/2021
HFSA Annual Scientific Meeting Programming Committee, Heart Failure Society of America, 9/1/2021 - 9/30/2022
Council on Clinical Cardiology Clincal Pharmacology, 8/16/2021 - Present
Budget & Finance Committee, American College of Clinical Pharmacy, 11/1/2020 - 10/31/2022
Abstract reviewer, Heart Failure Society of America, 2020 - Present
Notable Honors
2023, Travel Award, American College of Clinical Pharmacy (ACCP)
2023, Outstanding Paper Award, 2nd Place, American College of Clinical Pharmacy
2023, Top Downloaded Article, Wiley
2023, Top 5 Downloaded Papers, Journal of the American College of Clinical Pharmacy
2022, Frederick P. Siegel Innovative Teaching Award, University of Illinois Chicago Colleage of Pharmacy
2022, Editor's Choice Award, Journal of the American College of Clinical Pharmacy
2021, Letter of Commendation, Timothy Killeen
2021, Mentoring Award, American College of Clinical Pharmacy
2017, Fellow, American College of Cardiology (FACC),
Education
Degrees:
Pre-Pharmacy Studies, University of Illinois at Chicago, United States, 1992
Doctor of Pharmacy (with Honors), University of Illinois at Chicago, United States, 1996
Postgraduate Training:
Pharmacy Practice Residency, University of Illinois at Chicago, United States, 1997
Cardiovascular Pharmacotherapy Fellowship, University of Illinois at Chicago, United States, 1999
Licensures and Certifications
Basic Life Support Provider, American Heart Association, 1996 - Present
Acute Cardiac Life Support Provider, American Heart Association (Chgo), 1996 - Present
Board Certified Pharmacotherapy Specialist, Board of Pharmaceutical Specialties, 2015 - 2022
Added Qualifications in Cardiology, Board of Pharmaceutical Specialties, 2015 - 2022
Pharmacy-Based Immunization Delivery, American Pharmacists Association, 2020 - Present
Selected Presentations
DiDomenico, Robert. (2024 April 07). It’s all about the drugs: the latest in optimal medical therapy for SIHD. American College of Cardiology 73rd Annual Scientific Session & Expo. Atlanta, GA.
DiDomenico, Robert. (2023 November 11). TRANSFORM-HF debates (Con). American Heart Association. Philadelphia, PA.